-
Zindoxifene (INN;
former developmental code
names D-16726, NSC-341952) is a
nonsteroidal selective estrogen receptor modulator (SERM) that was
under development...
- that
includes zindoxifene, bazedoxifene, and pipendoxifene, as well as the
nonsteroidal estrogen D-15414 (the
major metabolite of
zindoxifene).
Michael Oettel;...
- The drug is a
member of the 2-phenylindole
group of SERMs,
along with
zindoxifene and pipendoxifene.
Bazedoxifene was
developed by
Pfizer following the...
- TAS-108 (SR-16234)
Toremifene Trioxifene TZE-5323 U-11555A U-11634 Y-134
Zindoxifene Zuclomifene Antagonists (R,R)-THC 7β-Hydroxy-DHEA
Chloroindazole Cytestrol...
- TAS-108 (SR-16234)
Toremifene Trioxifene TZE-5323 U-11555A U-11634 Y-134
Zindoxifene Zuclomifene Antagonists (R,R)-THC 7β-Hydroxy-DHEA
Chloroindazole Cytestrol...
- TAS-108 (SR-16234)
Toremifene Trioxifene TZE-5323 U-11555A U-11634 Y-134
Zindoxifene Zuclomifene Antagonists (R,R)-THC 7β-Hydroxy-DHEA
Chloroindazole Cytestrol...
- TAS-108 (SR-16234)
Toremifene Trioxifene TZE-5323 U-11555A U-11634 Y-134
Zindoxifene Zuclomifene Antagonists (R,R)-THC 7β-Hydroxy-DHEA
Chloroindazole Cytestrol...
- TAS-108 (SR-16234)
Toremifene Trioxifene TZE-5323 U-11555A U-11634 Y-134
Zindoxifene Zuclomifene Antagonists (R,R)-THC 7β-Hydroxy-DHEA
Chloroindazole Cytestrol...
- TAS-108 (SR-16234)
Toremifene Trioxifene TZE-5323 U-11555A U-11634 Y-134
Zindoxifene Zuclomifene Antagonists (R,R)-THC 7β-Hydroxy-DHEA
Chloroindazole Cytestrol...
-
major metabolite of the
selective estrogen receptor modulator (SERM)
zindoxifene (D-16726). D-15414 has high
affinity for the
estrogen receptor (ER) and...
